BRP PRESENTS ITS SECOND QUARTER RESULTS FOR FISCAL YEAR 2027

BRP reported Q2 FY27 revenue of $2,236.8M (+18.5% YoY) led by higher ORV shipments, but profitability deteriorated with net loss of $(136.8)M (vs +$57.1M) and normalized EBITDA down 34.9% to $138.8M, driven by Section 232 tariff impacts and a supplier restructuring hit of $74.8M (330bps) to gross margin. Despite the earnings deterioration, BRP raised FY27 guidance for normalized diluted EPS to $4.00–$4.50, while warning Q3 normalized diluted EPS is expected to be down ~50%–60% YoY due to increased tariff impacts. The company also launched BRP Financial Services (US retail financing) and continued capital returns with $231.7M in shareholder payouts over the first six months (dividends and buybacks).

Analysis

The market should look through the top-line beat and focus on the margin bridge: this is a revenue-share gain story being partially financed by lower profitability. The key issue is that tariff and supplier-restructuring costs are not one-off optics; they hit the cost base exactly when the company is trying to support share with more launches, higher R&D, and a financing push. That usually compresses near-term earnings quality and keeps the multiple capped even if the stock initially pops on raised guidance.

Relative winners are the cleaner ORV competitors and the dealers that can capture displaced demand if BRP has to spend harder to defend its shelf space. Polaris (PII) is the most obvious public read-through: if BRP’s share gains are being bought with margin sacrifice, PII can defend pricing without needing to match the same cadence of launches. The new captive finance arm is strategically useful, but in the short run it can also pull risk onto BRP’s balance sheet if dealer inventory or credit performance deteriorates.

The next catalyst is not this quarter’s beat; it is the Q3 setup, where management is already signaling a much weaker earnings step-down over the next 1-2 quarters. That creates a classic fade-the-strength setup if the stock rerates on the guidance raise before the market models the tariff drag into FY27 margins and tax rate normalization. The contrarian view is that the revenue momentum may be more durable than skeptics think, but the burden of proof is now on proving margin recovery, not just unit growth. What would falsify the short thesis: a visible rebound in gross margin back toward the high-teens and evidence that tariffs are being offset by pricing without share loss.

Key Decisions for Investors

• Short DOO/DOOO into any post-earnings strength; preferred horizon is 1-3 months as the market digests the Q3 EPS step-down and tariff drag. Risk/reward improves if the stock rerates on guidance first and then mean-reverts when margins reset lower.
• For defined risk, buy 2-4 month DOO/DOOO put spreads on rallies rather than outright shorting. The thesis is a multiple compression trade, not a collapse story; cap downside if management delivers an unexpected margin repair.
• Pair trade: long PII / short DOO on a 1-3 month horizon. BRP’s share gains look costlier, while PII should benefit if the ORV replacement cycle stays intact without comparable tariff-induced margin leakage.
• Do not chase the finance-services narrative until there is disclosure on credit losses, penetration, and funding cost. If dealer inventory rises or finance receivables expand faster than retail, reduce exposure to DOO immediately.
• Set a falsifier on next quarter: if normalized gross margin re-accelerates materially from the current trough and Q3 EPS is not down materially year over year, cover shorts and reassess.